Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
CDC releases new 12-dose treatment guidelines for latent TB infection

The Centers for Disease Control and Prevention (CDC) unveiled new guidelines Thursday for the treatment of latent tuberculosis infection (LTBI) in the U.S. with a 12-dose regimen, administered once-weekly under directly observed therapy (DOT). The current regimen requires daily drug administration over nine months, making the new treatment simpler and easier for patients.

Published
08 December 2011
From
Science Speaks
HIV and TB in Practice: Going beyond the clinic to eliminate TB and TB/HIV

Thanks to the following for their advice: Dr Liz Corbett,  Professor Helen Ayles and Professor Peter Godfrey-Faussett of the London School of Hygiene and Tropical

Published
06 December 2011
From
HIV & AIDS treatment in practice
UK: New tuberculosis cases fall by 5%

New cases of tuberculosis (TB) decreased by nearly 5% last year compared to 2009, the Health Protection Agency (HPA) has said.

Published
06 December 2011
From
Press Association
An intensive household counselling intervention reduces the burden of TB in ZAMSTAR study

An intensive ‘household counselling’ intervention (involving TB contact tracing, multiple home visits, TB and HIV counselling and screening with linkages to care) reduced the prevalence of culture-positive

Published
30 November 2011
From
HIV & AIDS treatment in practice
The implications of ZAMSTAR for research and policy

So what was the primary take-home message of this complex study, the one that policy makers and funders need to take to heart? Sending out counsellors to repeatedly make

Published
30 November 2011
From
HIV & AIDS treatment in practice
ART and TB prevention

This edition explores what is known about the potential benefits and limits of antiretroviral therapy (ART) for TB prevention and control.

Published
25 November 2011
From
HIV & AIDS treatment in practice
PEPFAR Scientific Advisory Board recommends accelerating scale up of HIV treatment

The Scientific Advisory Board (SAB) of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program met in September to discuss the results of the HIV Prevention Trials Network (HPTN) 052 trial. The 052 subcommittee made a list of six recommendations to U.S. Global AIDS Ambassador Eric Goosby and the Office of the Global AIDS Coordinator that the full board approved, with the first four listed in order of priority as defined by the SAB.

Published
17 November 2011
From
Science Speaks
What it means to be an HIV positive couple with a positive child

I am Innocent Bitandema, a 41-year-old peasant. I am married to Gloria Ahimbisibwe, a housewife aged 35 with four children. In 2004, I started coughing and I had on and off fever. When the cough became profuse, I went to the health centre where I was diagnosed with tuberculosis (TB). go →

Published
16 November 2011
From
Key Correspondents
New Six-Way Agreement Among Pharmas and NGOs will Speed Development of TB Drug Combinations

The Critical Path to TB Drug Regimens (CPTR) today announced an innovative agreement between AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization to share information on tuberculosis (TB) compounds within their respective drug pipelines to quickly identify and work together to develop the most promising TB drug regimen, regardless of sponsor.

Published
10 November 2011
From
Critical Path to TB Drug Regimens
Tuberculosis breakthrough as scientists get funds for 'electronic nose'

A team of Indian researchers are planning to have a prototype of an "electronic nose" that can detect tuberculosis from a person's breath in hospitals by October 2013, after receiving a $950,000 grant on Monday.

Published
08 November 2011
From
The Guardian

Filter by country